These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17762520)

  • 1. WIN-55,212-2 chronically implanted into the CA3 region of the dorsal hippocampus impairs learning: a novel method for studying chronic, brain-area-specific effects of cannabinoids.
    Barna I; Soproni K; Arszovszki A; Csabai K; Haller J
    Behav Pharmacol; 2007 Sep; 18(5-6):515-20. PubMed ID: 17762520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons.
    Hampson RE; Simeral JD; Kelly EJ; Deadwyler SA
    Hippocampus; 2003; 13(5):543-56. PubMed ID: 12921345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory encoding in hippocampal ensembles is negatively influenced by cannabinoid CB1 receptors.
    Hampson RE; Sweatt AJ; Goonawardena AV; Song D; Chan RH; Marmarelis VZ; Berger TW; Deadwyler SA
    Behav Pharmacol; 2011 Aug; 22(4):335-46. PubMed ID: 21558844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm.
    De Vry J; Jentzsch KR
    Behav Pharmacol; 2004 Feb; 15(1):13-20. PubMed ID: 15075622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: compound-specific and area-specific distribution within the brain.
    Barna I; Till I; Haller J
    Eur Neuropsychopharmacol; 2009 Aug; 19(8):533-41. PubMed ID: 19303746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity.
    Mouro FM; Ribeiro JA; Sebastião AM; Dawson N
    J Neurochem; 2018 Oct; 147(1):71-83. PubMed ID: 29989183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats.
    Hasanein P; Teimuri Far M
    Pharmacol Biochem Behav; 2015 Apr; 131():130-5. PubMed ID: 25689415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic and acute adenosine A
    Mouro FM; Batalha VL; Ferreira DG; Coelho JE; Baqi Y; Müller CE; Lopes LV; Ribeiro JA; Sebastião AM
    Neuropharmacology; 2017 May; 117():316-327. PubMed ID: 28235548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory.
    Clarke JR; Rossato JI; Monteiro S; Bevilaqua LR; Izquierdo I; Cammarota M
    Neurobiol Learn Mem; 2008 Sep; 90(2):374-81. PubMed ID: 18524639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors.
    Pamplona FA; Takahashi RN
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):88-92. PubMed ID: 16406322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CB1 receptor agonist, WIN 55,212-2, dose-dependently disrupts object recognition memory in adult rats.
    Baek Jh; Zheng Y; Darlington CL; Smith PF
    Neurosci Lett; 2009 Oct; 464(1):71-3. PubMed ID: 19666083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term memory is modulated by the spontaneous release of endocannabinoids: evidence from hippocampal population codes.
    Deadwyler SA; Goonawardena AV; Hampson RE
    Behav Pharmacol; 2007 Sep; 18(5-6):571-80. PubMed ID: 17762525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hippocampal administration of a cannabinoid receptor agonist WIN 55,212-2 on spontaneous object and place recognition in rats.
    Suenaga T; Ichitani Y
    Behav Brain Res; 2008 Jul; 190(2):248-52. PubMed ID: 18374994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
    Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
    Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid-induced tolerance is associated with a CB1 receptor G protein coupling switch that is prevented by ultra-low dose rimonabant.
    Paquette JJ; Wang HY; Bakshi K; Olmstead MC
    Behav Pharmacol; 2007 Dec; 18(8):767-76. PubMed ID: 17989514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice.
    Castañé A; Maldonado R; Valverde O
    Br J Pharmacol; 2004 Aug; 142(8):1309-17. PubMed ID: 15265804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.
    Oltmanns MH; Samudre SS; Castillo IG; Hosseini A; Lichtman AH; Allen RC; Lattanzio FA; Williams PB
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):104-15. PubMed ID: 18201139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain.
    Moranta D; Esteban S; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):61-72. PubMed ID: 18709357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory deficits induced by chronic cannabinoid exposure are prevented by adenosine A
    Mouro FM; Köfalvi A; André LA; Baqi Y; Müller CE; Ribeiro JA; Sebastião AM
    Neuropharmacology; 2019 Sep; 155():10-21. PubMed ID: 31103616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.